Market Cap 4.19B
Revenue (ttm) 2.39B
Net Income (ttm) 235.61M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 11.17
Profit Margin 9.85%
Debt to Equity Ratio 0.43
Volume 225
Avg Vol 530
Day's Range N/A - N/A
Shares Out 446.25M
Stochastic %K 99%
Beta 1.13
Analysts Strong Sell
Price Target N/A

Company Profile

Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and markets specialty and branded pharmaceutical products in Africa, the Middle East, the Americas, Europe CIS, Australasia, and Asia. It operates through Commercial Pharmaceuticals and Manufacturing segments. The company offers injectables for therapeutic areas, such as anaesthetics, anticoagulants, antithrombotic agents, analgesics, and hormone replacement medicines under the Arixtra, Diprivan, Fraxiparine, Marcain...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 27 31 580 8600
Address:
Aspen Place, 9 Rydall Vale Park Douglas Saunders Drive La Lucia Ridge, Durban, South Africa
Latest News on APNHY
No data available.